NZD/USD chart - Trading View
NZD/USD erases early gains, trades 0.26% lower on the day at 0.5941 at 08:45 GMT.
The pair has paused a 5 day winning streak as upside remains capped at 21-EMA resistance.
5-DMA has turned, MACD is on verge of bullish crossover on signal line and Stochs and RSI have rolled over from oversold levels.
Major trend in the pair is bearish. However, minor trend is turning slightly bullish, raising scope for upside.
'Death Cross' (bearish 50-DMA crossover on 200-DMA) on the daily charts could limit gains.
Price action has broken above 38.2% Fib retracement (0.5960) and breakout at 21-EMA will see further upside.
Failure to break 21-EMA resistance and retrace below 5-DMA negates any bullish bias.
Focus shall be on the coronavirus data for near-term direction. US Michigan Consumer Sentiment may offer additional volatility.
Support levels - 0.5857 (5-DMA), 0.5772 (23.6% Fib)
Resistance levels - 0.6016 (21-EMA), 0.6112 (50% Fib)


FxWirePro: USD/CAD gains as broad dollar strength lifts pair
FxWirePro: USD/ZAR rises as dollar gains on Fed hike bets
FxWirePro- Major Pair levels and bias summary
FxWirePro- Major Crypto levels and bias summary
UBS Predicts Potential Fed Rate Cut Amid Strong US Economic Data
Hawkish Fed Fuels Gold Sell-off: Gold Dives Below $4300 Amidst Rate Hike Fears
Gold Prices Fall Amid Rate Jitters; Copper Steady as China Stimulus Eyed
Stock Futures Dip as Investors Await Key Payrolls Data
FxWirePro: USD/CAD extends advance as stronger dollar and falling oil weighs on loonie
FxWirePro: USD/ZAR retreats as markets await U.S.-Iran talks and South Africa data
Wall Street Analysts Weigh in on Latest NFP Data
FxWirePro: GBP/NZD uptrend loses steam, remains on bullish path
S&P 500 Relies on Tech for Growth in Q4 2024, Says Barclays
FxWirePro: EUR/AUD recovers some ground, but outlook remains bearish
FxWirePro: AUD/USD softens as Australian unemployment rate nears 5-year high
European Stocks Rally on Chinese Growth and Mining Merger Speculation
China’s Growth Faces Structural Challenges Amid Doubts Over Data 



